Co-Op, Immuno-Oncology Research

Moderna; Cambridge (MA); On-site; USD 25,000 - 36,000; Full time

Job summary

Moderna is seeking an Immuno-Oncology Research Co-op to support mRNA-based cancer therapies, applying cell and molecular biology techniques to advance immunotherapy research.

The role involves hands-on work with primary cells, assays, and data analysis in Cambridge, MA, with a 70/30 in-office model. January 18 to June 25, 2027, offers an immersive experience in a cutting-edge team.

Qualifications

• Enrolled in a Bachelor's or Master's STEM program.
• Prior lab or co-op experience preferred.
• Technical skills in mammalian tissue culture, protein detection, assay troubleshooting, and flow cytometry advantageous.
• Self-motivated with strong communication skills.

Responsibilities

• Conduct experiments involving primary cell isolation, cell culture, ELISA/MSD assays, flow cytometry, and tissue processing.
• Analyze data and present findings to the team.
• Maintain lab safety and documentation.
• Collaborate with colleagues to advance immunotherapy research.

Skills

Mammalian tissue culture

Protein detection

Assay troubleshooting

Flow cytometry

Strong communication

Education

Bachelor's or Master's STEM program

Tools

ELISA

MSD assays

Job description

Role:

Immuno-Oncology Research Co-op supporting mRNA-based cancer therapies at Moderna, focusing on cell and molecular biology techniques to advance immunotherapy research.

Responsibilities:

• conduct experiments involving primary cell isolation, cell culture, ELISA/MSD assays, flow cytometry, and tissue processing
• analyze data
• present findings
• maintain lab safety and documentation

Requirements:

• enrolled in a Bachelor's or Master's STEM program
• prior lab or co-op experience preferred
• technical skills in mammalian tissue culture, protein detection, assay troubleshooting, and flow cytometry advantageous
• self-motivated with strong communication skills

Preferred:

• GPA ≥3.5
• ability to work independently and in teams
• keen attention to detail
• interest in immuno-oncology

HighValue:

focus on cancer immunotherapy, mRNA modalities, early-stage research supporting drug development, and in vitro/in vivo model work.

WorkSetup:

in-person at Cambridge, MA, with a 70/30 in-office work model.

Duration:

January 18 – June 25, 2027.